---
title: "HAERS: Net profit of 287 million yuan in 2024, a year-on-year increase of 14.72%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236808268.md"
description: "HAERS announced that the operating revenue for 2024 is expected to be 3.332 billion yuan, a year-on-year increase of 38.40%. The net profit attributable to shareholders of the listed company is expected to be 287 million yuan, a year-on-year increase of 14.72%. The basic earnings per share is expected to be 0.63 yuan/share, a year-on-year increase of 16.67%. The company plans to distribute a cash dividend of 1.5 yuan for every 10 shares to all shareholders, with no bonus shares issued and no capital reserve converted into share capital"
datetime: "2025-04-21T13:46:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236808268.md)
  - [en](https://longbridge.com/en/news/236808268.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236808268.md)
generator: "portal-rs"
---

# HAERS: Net profit of 287 million yuan in 2024, a year-on-year increase of 14.72%

HAERS announced that the operating revenue for 2024 is 3.332 billion yuan, a year-on-year increase of 38.40%. The net profit attributable to shareholders of the listed company is 287 million yuan, a year-on-year increase of 14.72%. The basic earnings per share is 0.63 yuan/share, a year-on-year increase of 16.67%. The company plans to distribute a cash dividend of 1.5 yuan for every 10 shares to all shareholders, with no bonus shares issued and no capital reserve fund converted into share capital

### Related Stocks

- [002615.CN](https://longbridge.com/en/quote/002615.CN.md)

## Related News & Research

- [Nasdaq Futures Plunge as Rising Bond Yields Drive Chip Selloff](https://longbridge.com/en/news/296216952.md)
- [09:25 ETThe Brothers That Just Do Gutters Encourages Homeowners to Prepare for the Great American Leaf Drop](https://longbridge.com/en/news/296235825.md)
- [BUZZ-Life insurance stock weakness after Mark Walter headlines overdone, Evercore says](https://longbridge.com/en/news/296214606.md)
- [CSPC Innovation Pharmaceutical: Biopharma licensing and product launches drove record revenue and profit growth](https://longbridge.com/en/news/296129143.md)
- [Vilniaus Baldai appoints Grant Thornton Baltic as auditor for 2026-27 financial statements](https://longbridge.com/en/news/296367543.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**